Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jim Blair
AddedMar 31, 2024
UpdatedMay 31, 2026
Jim Blair

Jim Blair

Board Member, Clovis Oncology

Crunchbase

Jim Blair's Career

Clovis Oncology
Clovis Oncology

Boulder, CO, US

Board Member· Board
Gene Sciences
Gene Sciences

San Diego, CA, US

CEO· C-Suite · Management
Axial Therapeutics
Axial Therapeutics

Woburn, MA, US

Board Member· Board
Applied Proteomics
Applied Proteomics

San Diego, CA, US

Board Member· Board
Astute Medical
Astute Medical

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jim Blair's Career

Clovis Oncology
Clovis Oncology
Public$145M4132009Boulder, CO, US
Board Member· Board

Leadership at Clovis Oncology

Rick FairRick FairBoard Member
Paul H. KlingensteinPaul H. KlingensteinBoard Member
Bob AzelbyBob AzelbyBoard Member
Patrick J. MahaffyPatrick J. MahaffyFounder
Brian AtwoodBrian AtwoodBoard Member
Gene Sciences
Gene Sciences
Public$8M62016San Diego, CA, US
CEO· C-Suite · Management

Leadership at Gene Sciences

Fei YangFei YangFounder

Similar to Gene Sciences

GeneicdGeneicdScottsdale, AZ, USBiotechnology, Genomicsest. 2019GeneicdScottsdale, AZ, US · est. 2019

GENEICD: A leading biotech firm innovating in genomics for improved patient health.

Seed · $152.5k7
Dnalite TherapeuticsDnalite TherapeuticsSan Francisco, CA, USest. 2016Dnalite TherapeuticsSan Francisco, CA, US · est. 2016

DNALite Therapeutics: An early-stage biotech company specializing in preclinical research.

Series A · $8.3M9
Gene SolutionsGene SolutionsCharlottesville, VA, USDiagnostics, Genomicsest. 2006Gene SolutionsCharlottesville, VA, US · est. 2006

Gene Solutions: Identifying disease-causing mutations through mitochondrial genomics.

Seed · $2.9M8
GeneDx HoldingsGeneDx HoldingsStamford, CT, USGenetic Testingest. 2017GeneDx HoldingsStamford, CT, US · est. 2017

Connecticut-based GeneDx, a software company merging diagnostics and data science for personalized health insights.

Public · $941M919
Axial Therapeutics
Axial Therapeutics
Series C$110.9M292016Woburn, MA, US
Board Member· Board

Leadership at Axial Therapeutics

Jeffrey YoungJeffrey YoungCo-Founder
Sakae AsanumaSakae AsanumaBoard Member
Ron RenaudRon RenaudBoard Member
Elaine HsiaoElaine HsiaoCo-Founder
Eric De La FortelleEric De La FortelleBoard Member
David DonabedianDavid DonabedianCo-Founder & CEO
Applied Proteomics
Applied Proteomics
Series C$54.5M322006San Diego, CA, US
Board Member· Board

Leadership at Applied Proteomics

Lim Kok ThayLim Kok ThayBoard Member
Daniel HillisDaniel HillisFounder
Peter KlemmPeter KlemmCEO
Danny HillisDanny HillisBoard Member
Dan AbrutynDan AbrutynBoard Member
R Erik HolmlinR Erik HolmlinBoard Member
Astute Medical
Astute Medical
$209.1M02007San Diego, CA, US
Board Member· Board

Leadership at Astute Medical

Phil GutryPhil GutryBoard Member
Fred DotzlerFred DotzlerBoard Member
David DouglassDavid DouglassBoard Member
Paul McPhersonPaul McPhersonBoard Member
Chris HibberdChris HibberdBoard Member
Kim D. BlickenstaffKim D. BlickenstaffBoard Member

People Similar to Jim Blair

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoJoseph CardozoJoseph CardozoCEO · GeneCentrixGreg CritchfieldGreg CritchfieldBoard Member · Sera PrognosticsWalker LongWalker LongCEO · GeneBiologyMichael WongMichael WongCEO · SequrJames KolleggerJames KolleggerBoard Member · Genesys PartnersAndrew BarnellAndrew BarnellCo-Founder · Geneoscopy